-
NEWS
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters CorporationBD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business and the...
-
NEWS
BD Reports First Quarter Fiscal 2026 Financial ResultsRevenue of $5.3 billion increased 1.6% as reported, 0.4% FXN New BD revenue increased 2.5% FXN GAAP and adjusted diluted EPS of $1.34 and $2.91, respectively Combination of BD's Biosciences and...
-
BLOG
SWE RecognitionBD innovators and a rising leader recognized by the Society of Women Engineers